Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-25-003067
Filing Date
2025-03-06
Accepted
2025-03-06 13:48:18
Documents
1
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3847
  Complete submission text file 0001225208-25-003067.txt   5305
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Issuer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 358 SOUTH MAIN STREET BURLINGTON NC 27215
Business Address
Fonseca Lidia (Reporting) CIK: 0001454944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03619 | Film No.: 25714593